You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
兆科眼科-B(06622.HK)與醫渡科技旗下關聯公司簽訂意向書

格隆匯12月16日丨兆科眼科-B(06622.HK)發佈公吿,公司與醫療大數據技術和人工智能解決方案提供商醫渡科技(02158.HK)旗下專注於生命科學解決方案的下屬關聯公司簽訂一份意向書,以期加快中國眼科市場創新臨牀研究項目的發展,藉此攜手為中國眼疾患者提供更佳的醫療護理及支援。

根據意向書,公司將與醫渡科技旗下專注於生命科學解決方案的下屬關聯公司天津開心生活科技有限公司(“開心生活科技”)合作,初步聚焦於以下三大範疇:

1.培育臨牀研究人才。雙方將向臨牀試驗中心的醫療保健專業人員提供臨牀研究教育課程,以便推廣良好臨牀試驗常規及知識。

2.建立臨牀研究網絡。雙方將運用資源建立共同臨牀研究網絡,以便提升產品開發效率及改善生命週期管理。

3.開發數字化臨牀研究模型。憑藉公司強勁的眼科藥物研究及開發能力以及開心生活科技豐富的技術專門知識,雙方將攜手使臨牀研究模型邁向數字化,促成推出虛擬臨牀試驗等舉措,可望提高臨牀試驗績效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account